Sanofi shells out $11.6bn on Bioverativ

22nd January 2018 Uncategorised 0

Sanofi is fortifying its presence in the field of blood disorders through the purchase of Bioverativ in a deal valued at some $11.6 billion.

More: Sanofi shells out .6bn on Bioverativ
Source: News